Context Therapeutics Inc (CNTX NASDAQ) stock market data APIs
$0.3591
0.01(2.8%)
as of September 4, 2026
Try our APIs with
free plan!
Context Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Prev. Close
0.3591
Open
0.3667
High
0.3736
Low
0.3482
52 wk Range
0.347-3.62
Market Cap
33 233 K
Shares Outstanding
91 879 K
EPS
-0.15
Beta
1.688
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Context Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Context Therapeutics Inc data using free add-ons & libraries
Get Context Therapeutics Inc Fundamental Data
Context Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -48 706 952
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Context Therapeutics Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-05
- EPS/Forecast: -0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Context Therapeutics Inc News
New
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Company Logo Opportunities center on frontline immunotherapy combinations, biomarker and companion diagnostics, AI-enabled pathology, minimally invasive screening, precision therapies for uterine sar...
Context Expands Q2 Net Loss As Pipeline Advances; Stock Drops 23% In Overnight Market
(RTTNews) - Context Therapeutics Inc. (CNTX) reported financial results for the second quarter ended June 30, 2026, reflecting a wider year-over-year loss as it prepares to progress its clinical pipel...
Context Gains Addition To Russell 2000 And Russell 3000 Indices
(RTTNews) - Context Therapeutics Inc. (CNTX), a clinical-stage biopharmaceutical company, on Monday announced the addition of the company to the small-cap Russell 2000 and Russell 3000 indices as on J...
Maxim Says Context Therapeutics (CNTX)’s Share Pullback Is an Overreaction; Remains Bullish
Context Therapeutics Inc. (NASDAQ:CNTX) ranks among the overlooked penny stocks to buy right now, supported by strong upside potential. A sharp stock selloff tied to early clinical data has drawn a se...
Get Context Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
